In-Vitro Colorectal Cancer Screening Tests Market share to reach $900mn by 2023 - PowerPoint PPT Presentation

About This Presentation
Title:

In-Vitro Colorectal Cancer Screening Tests Market share to reach $900mn by 2023

Description:

Get more details @ Global in-vitro colorectal cancer screening tests market is marked by strategic associations, mergers and acquisitions, and partnerships to expand product range. Major industry players are Alere, Abbott, Eiken Chemical, Siemens Healthcare and Beckman Coulter. Strict government policies challenge new players from entering the industry. – PowerPoint PPT presentation

Number of Views:71

less

Transcript and Presenter's Notes

Title: In-Vitro Colorectal Cancer Screening Tests Market share to reach $900mn by 2023


1
In-Vitro Colorectal Cancer Screening Tests Market
to grow at over 5 CAGR from 2016 to 2023 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from In-vitro Colorectal Cancer
Screening Tests Market
  • Global Market Insights, Inc., says In-vitro
    colorectal cancer screening tests industry size
    is estimated to hit USD 903 million by 2023.
  • Technological developments in healthcare to
    acquire accurate results in early diagnosis will
    propel in-vitro colorectal cancer screening tests
    market size over the coming years.
  • Furthermore, government legislations mandating
    cancer diagnosis and screening are expected to
    boost the market trends. For instance, EU
    collaborated with IARC (International Agency for
    Research on Cancer) to produce the first edition
    of quality assurance guidelines for colorectal
    cancer diagnosis and screening to improve the
    quality of cancer diagnosis.
  • Taking into consideration the tests trends,
    in-vitro colorectal cancer screening tests market
    is segmented into biomarker tests, fecal occult
    blood tests, and colorectal cancer(CRC) DNA
    screening tests.
  • Colorectal cancer (CRC) DNA screening tests
    market size is expected to grow at a rate of 10
    over the period of 2016-2023, owing to high level
    of test accuracy and sensitivity.

3
Continued...
  • Considering the regional outlook, North America
    in-vitro colorectal cancer screening tests
    market, which dominated the regional landscape in
    2015, is projected to witness a considerable
    growth over the coming years, driven by rise in
    healthcare spending, enhanced healthcare
    amenities, high level of patient awareness, and
    introduction of supportive government
    legislations related to screening tests. U.S. is
    expected to be a key regional revenue pocket.
  • Moreover, recommendation of introducing effective
    screening tests in healthcare sector by EU along
    with favorable changes in existing tests will
    drive Europe in-vitro colorectal cancer screening
    tests industry revenue over the coming years.
  • Rising elderly population base and inactive
    lifestyles are estimated to push Asia Pacific
    in-vitro colorectal cancer screening tests
    industry growth over the coming six years. Japan,
    South Korea, China, and Malaysia are expected to
    be the major regional revenue contributors.
  • Key industry participants include Eiken Chemical
    Company Limited, Abbott Molecular, CompanionDx
    Reference Lab LLC, Alere Incorporation, Sysmex
    Corporation, Quest Diagnostics, Beckman Coulter,
    Merck Millipore Corporation, and Epigenomics AG.

4
Germany In-Vitro Colorectal Cancer Screening
Tests Market Size, By Type, 2012-2023 (USD
Million)

5
Table of Content
Chapter 1. Methodology 1.1. Methodology
1.1.1. Initial
data exploration 1.1.2. Statistical model and
forecast 1.1.3. Industry insights and
validation 1.1.4. Market definition 1.1.5.
Market definition and forecast parameters
1.2. Data sources 1.2.1.
Secondary 1.2.2. Primary Chapter 2.
Executive Summary 2.1. In-Vitro colorectal
cancer screening tests industry 3600 synopsis,
2013 - 2024 2.1.1. Business trends 2.1.2.
Test type trends 2.1.3. Regional trends
6
Table of Content
Chapter 3. In-Vitro Colorectal Cancer Screening
Tests Industry Insights 3.1. Industry
segmentation 3.2. Industry landscape, 2013
2024 3.3. Industry impact forces 3.3.1.
Growth drivers 3.3.1.1. Improvements in
colorectal cancer screening through non-invasive
methods 3.3.1.2. Advancements in the field of
diagnosis precision 3.3.1.3. Rising
prevalence of colorectal cancer 3.3.1.4.
Cost-efficient and high-speed DNA
sequencing 3.3.2. Industry pitfalls
challenges 3.3.2.1. Lack of uniform cancer
screening guidelines in Asia Pacific 3.3.2.2.
Inadequate reimbursement coverage 3.3.2.3.
Shortage of trained staff in developing regions
7
Table of Content
3.4. Regulatory landscape 3.4.1.
U.S 3.4.2. Europe 3.4.3. China 3.5.
Technology landscape 3.6. Growth potential
analysis 3.6.1. By test type 3.7. Porters
analysis 3.8. Competitive landscape 3.8.1.
Strategy dashboard 3.9. PESTEL analysis
8

Browse Full Market Research Report On In-vitro
Colorectal Cancer Screening Tests Market _at_
http//bit.ly/2oodw2i Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/451 https//www.gminsigh
ts.com/request-sample/detail/49
9
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com